Grail GRAL 深 沪
交易中 07-02 11:19:50 美东时间
70.11
+2.000
+2.94%
华盛通- 最 高71.41
- 今 开68.99
- 成交量 7.61万股
- 最 低 68.98
- 昨 收 68.11
- 总市值 30.09亿
- 52周最高 118.84
- 市盈率 静 --
- 换手率 0.18%
- 52周最低 29.95
- 委 比 -88.44%
- 总股本 4291.66万
- 历史最高 118.84
- 量 比 0.43
- 振 幅 3.57%
- 历史最低 12.33
- 每 手 1
- 风险率 23.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dynatrace plans FedRAMP high authorization to advance federal security needs
Dynatrace (DT) announced on Thursday it plans to pursue FedRAMP High authorization to expand its presence in the public sector market. This authorization would allow the company to serve U.S. federal ...
今天 21:52
Grail Inc（GRAL）受损股东可牵头提起证券欺诈诉讼
Glancy Prongay Wolke & Rotter LLP律师事务所宣布，允许存在Grail, Inc.（纳斯达克代码：GRAL）投资损失的投资...
07-01 00:06
Regulator should reject NextEra-Dominion power megadeal, senator says
The Federal Energy Regulatory Commission should reject NextEra Energy's (NEE) proposed $67B acquisition of Dominion Energy (D), Senator Angus King said Monday, believing the deal would consolidate t...
06-30 06:48
Robbins LLP敦促投资Grail, Inc.遭遇损失的GRAL股东联系律所了解主导集体诉讼相关信息
罗宾斯律师事务所代表2025年5月13日至2026年2月19日期间买入/收购纳斯达克上市企业圣杯公司（Grail, Inc.，代码GRAL）证券的投资者，提起联...
06-25 07:17
Grail关键试验失败引集体诉讼 股价单日腰斩
多癌种早期检测公司Grail， Inc．正面临证券欺诈集体诉讼。此前公司宣布，其关键NHS-Galleri试验未达到主要终点，导致股价暴跌超过50%。投资者...
06-12 03:20
Grail关键癌症试验失败引发集体诉讼，投资者索赔截至8月4日
多癌种早期检测公司Grail， Inc．（NASDAQ： GRAL）正面临证券欺诈集体诉讼。此前公司宣布，其关键的NHS-Galleri试验未达到主要终点...
06-11 03:27
美股大行评级 | Ciena、Rubrik获多家大行上调目标价；库珀医疗、Guidewire软件、露露乐蒙等遭多家大行下调目标价
今日重点评级关注：瑞银：维持DraftKings"买入"评级，目标价从43美元升至49美元；Needham：维持Planet Labs"买入"评级，目标价从40美元升至53美元
06-08 11:33
BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses
BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses May 30 (Reuters) - Grail Inc GRAL.O : GRAIL REPORTS FULL RESULTS FROM NHS-GALLERI TRIAL DEMONSTRATING SUBSTANTIAL REDUCTION IN STAGE IV CANCER DIAGNOSES AT 2026 ASCO ANNUAL MEETIN
05-30 20:14
Full Transcript: Workday Q1 2027 Earnings Call
Workday (NASDAQ:WDAY) released first-quarter financial results and hosted an ea...
05-22 05:32
Grail posts MCED study presentation on reducing emergency cancer diagnoses via ED
Grail posts MCED study presentation on reducing emergency cancer diagnoses via ED Grail released a medical research poster evaluating how multi-cancer early detection blood testing could reduce emergency department involvement at cancer diagnosis in a modeled Medicare-age screening cohort. The analy
05-19 15:41
